Commonwealth Equity Services’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.34M Buy
44,052
+1,173
+3% +$230K 0.01% 986
2026
Q1
$8.4M Sell
42,879
-3,042
-7% -$591K 0.01% 994
2025
Q4
$7.97M Sell
45,921
-10,047
-18% -$1.83M 0.01% 1019
2025
Q3
$10.7M Sell
55,968
-2,651
-5% -$470K 0.01% 887
2025
Q2
$10.5M Sell
58,619
-2,787
-5% -$484K 0.01% 870
2025
Q1
$10.4M Buy
61,406
+33,038
+116% +$5.43M 0.01% 844
2024
Q4
$4.28M Buy
28,368
+4,298
+18% +$668K 0.01% 1340
2024
Q3
$3.74M Buy
24,070
+250
+1% +$37.3K 0.01% 1418
2024
Q2
$3.26M Buy
23,820
+49
+0.2% +$6.71K 0.01% 1467
2024
Q1
$3.16M Buy
23,771
+306
+1% +$39.7K 0.01% 1457
2023
Q4
$3.23M Buy
23,465
+913
+4% +$120K 0.01% 1379
2023
Q3
$2.75M Sell
22,552
-6,988
-24% -$931K 0.01% 1393
2023
Q2
$4.15M Buy
29,540
+8,215
+39% +$1.13M 0.01% 1141
2023
Q1
$3.02K Buy
21,325
+58
+0.3% +$8.3K 0.01% 1284
2022
Q4
$3.33M Sell
21,267
-281
-1% -$40.4K 0.01% 1186
2022
Q3
$2.64M Buy
21,548
+444
+2% +$58.5K 0.01% 1248
2022
Q2
$2.81M Buy
21,104
+633
+3% +$86.3K 0.01% 1214
2022
Q1
$2.8M Sell
20,471
-1,153
-5% -$161K 0.01% 1278
2021
Q4
$3.74M Buy
21,624
+692
+3% +$105K 0.01% 1086
2021
Q3
$3.04M Sell
20,932
-614
-3% -$89.8K 0.01% 1166
2021
Q2
$2.84M Buy
21,546
+405
+2% +$53K 0.01% 1197
2021
Q1
$2.71M Buy
21,141
+1,677
+9% +$207K 0.01% 1126
2020
Q4
$2.32M Sell
19,464
-728
-4% -$88.7K 0.01% 1144
2020
Q3
$2.31M Sell
20,192
-1,461
-7% -$173K 0.01% 1013
2020
Q2
$2.47M Buy
21,653
+4,781
+28% +$507K 0.01% 921
2020
Q1
$1.35M Buy
16,872
+1,574
+10% +$163K 0.01% 1109
2019
Q4
$1.63M Sell
15,298
-609
-4% -$63.5K 0.01% 1148
2019
Q3
$1.7M Sell
15,907
-402
-2% -$41.3K 0.01% 1058
2019
Q2
$1.66M Sell
16,309
-416
-2% -$40K 0.01% 1055
2019
Q1
$1.5M Sell
16,725
-1,148
-6% -$99.5K 0.01% 1062
2018
Q4
$1.49M Sell
17,873
-218
-1% -$20.4K 0.01% 987
2018
Q3
$1.95M Sell
18,091
-203
-1% -$22.3K 0.01% 936
2018
Q2
$2.01M Buy
18,294
+23
+0.1% +$2.4K 0.01% 897
2018
Q1
$1.83M Buy
18,271
+1,552
+9% +$159K 0.01% 915
2017
Q4
$1.65M Sell
16,719
-1,570
-9% -$149K 0.01% 948
2017
Q3
$1.71M Buy
18,289
+975
+6% +$104K 0.01% 888
2017
Q2
$1.93M Buy
17,314
+275
+2% +$29.1K 0.01% 807
2017
Q1
$1.67M Buy
17,039
+966
+6% +$92.1K 0.01% 836
2016
Q4
$1.48M Sell
16,073
-39
-0.2% -$3.36K 0.01% 852
2016
Q3
$1.36M Buy
16,112
+52
+0.3% +$4.37K 0.01% 857
2016
Q2
$1.31M Buy
16,060
+1,058
+7% +$80.6K 0.01% 850
2016
Q1
$1.07M Sell
15,002
-867
-5% -$58.1K 0.01% 914
2015
Q4
$1.13M Buy
15,869
+1,727
+12% +$116K 0.01% 869
2015
Q3
$869K Buy
14,142
+3,418
+32% +$239K 0.01% 963
2015
Q2
$778K Buy
10,724
+127
+1% +$9.38K 0.01% 1092
2015
Q1
$814K Sell
10,597
-703
-6% -$50.3K 0.01% 1060
2014
Q4
$758K Buy
11,300
+1,082
+11% +$68.3K 0.01% 1039
2014
Q3
$620K Buy
10,218
+840
+9% +$51.8K 0.01% 1123
2014
Q2
$550K Buy
9,378
+513
+6% +$30K 0.01% 1183
2014
Q1
$513K Sell
8,865
-198
-2% -$10.6K 0.01% 1145
2013
Q4
$485K Buy
9,063
+173
+2% +$10.3K 0.01% 1149
2013
Q3
$549K Buy
8,890
+52
+0.6% +$3.11K 0.01% 1043
2013
Q2
$536K Buy
+8,838
New +$527K 0.01% 987

Other funds holding DGX

Commonwealth Equity Services's DGX Position: Q2 2026 in Review

Commonwealth Equity Services increased its Quest Diagnostics (DGX) stake by 2.7% in Q2 2026, buying an estimated $230K and bringing the position to 44,052 shares worth $9.34M. The position accounts for 0.01% of the portfolio, ranked #986.

Commonwealth Equity Services first reported a position in DGX in Q2 2013 and has held it in 53 quarters since. The position peaked at $10.7M in Q3 2025. 376 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Commonwealth Equity Services held 44,052 shares of Quest Diagnostics worth $9.34M as of Q2 2026.
  • Commonwealth Equity Services bought 1,173 Quest Diagnostics shares in Q2 2026, an estimated $230K.
  • Quest Diagnostics made up 0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #986 holding.
  • Commonwealth Equity Services first reported a position in Quest Diagnostics in Q2 2013 and has held it in 53 quarters since.
  • Commonwealth Equity Services's Quest Diagnostics position peaked at $10.7M in Q3 2025.
  • 376 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.